Combination of MDM2 inhibition with milademetan and MEK inhibition leads to improved anti-tumor activity in cancer models harboring WT TP53. (October 2022)

Record Type:: Journal Article
Title:: Combination of MDM2 inhibition with milademetan and MEK inhibition leads to improved anti-tumor activity in cancer models harboring WT TP53. (October 2022)
Main Title:: Combination of MDM2 inhibition with milademetan and MEK inhibition leads to improved anti-tumor activity in cancer models harboring WT TP53
Authors:: Tirunagaru, V.
Singh, K.
Pei, X.
Doebele, R.C.
Abstract:
Is Part Of:: European journal of cancer. Volume 174(2022)Supplement 1
Journal:: European journal of cancer
Issue:: Volume 174(2022)Supplement 1
Issue Display:: Volume 174, Issue 1 (2022)
Year:: 2022
Volume:: 174
Issue:: 1
Issue Sort Value:: 2022-0174-0001-0000
Page Start:: S20
Page End:: S21
Publication Date:: 2022-10
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(22)00858-9 ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24177.xml